Cornerstone pharmaceuticals to present pancreatic cancer, clear cell sarcoma and biliary tract cancer research featuring cpi-613® (devimistat) at the 2022 american society of clinical oncology (asco) annual meeting

Cranbury, nj, june 01, 2022 (globe newswire) -- cornerstone pharmaceuticals, inc. (“cornerstone” or the “company”), a company focused on rare cancer therapeutics and formerly known as rafael pharmaceuticals, today announced that the company and its partners will present three abstracts at the american society of clinical oncology (asco) annual meeting taking place june 3 – june 7, 2022 in chicago.
RFL Ratings Summary
RFL Quant Ranking